Cargando…

Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics

Alzheimer’s disease (AD) progressively inflicts impairment of synaptic functions with notable deposition of amyloid-β (Aβ) as senile plaques within the extracellular space of the brain. Accordingly, therapeutic directions for AD have focused on clearing Aβ plaques or preventing amyloidogenesis based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Hyomin, Shin, Heewon, Hong, Seungpyo, Kim, YoungSoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Brain and Neural Sciences 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194638/ https://www.ncbi.nlm.nih.gov/pubmed/35673997 http://dx.doi.org/10.5607/en22004

Ejemplares similares

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
por: Lee, Jinny Claire, et al.
Publicado: (2019)

Carprofen alleviates Alzheimer-like phenotypes of 5XFAD transgenic mice by targeting the pathological hallmarks induced by amyloid-β aggregation
por: Lee, Donghee, et al.
Publicado: (2023)

Alzheimer's Disease Diagnosis Using Misfolding Proteins in Blood
por: Lee, HeeYang, et al.
Publicado: (2020)

Oligomerization and Conformational Change Turn Monomeric β-Amyloid and Tau Proteins Toxic: Their Role in Alzheimer’s Pathogenesis
por: Penke, Botond, et al.
Publicado: (2020)

Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system
por: Kim, YoungSoo, et al.
Publicado: (2019)

Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?
por: Jeong, Woo-jin, et al.
Publicado: (2018)

The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
por: Kent, Sarah A., et al.
Publicado: (2020)

Serotonin Promotes Serum Albumin Interaction with the Monomeric Amyloid β Peptide
por: Litus, Ekaterina A., et al.
Publicado: (2021)

Mechanisms of U87 Astrocytoma Cell Uptake and Trafficking of Monomeric versus Protofibril Alzheimer’s Disease Amyloid-β Proteins
por: Li, Yali, et al.
Publicado: (2014)

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model
por: Cho, Soo Min, et al.
Publicado: (2014)

Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
por: Zhang, Haolin, et al.
Publicado: (2023)

Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
por: Pfundstein, Grant, et al.
Publicado: (2022)

Fluorescent indolizine derivative YI-13 detects amyloid-β monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model
por: Kim, DaWon, et al.
Publicado: (2020)

Correction: Fluorescent indolizine derivative YI-13 detects amyloid-β monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model
por: Kim, DaWon, et al.
Publicado: (2021)

Aminostyrylbenzofuran Directly Reduces Oligomeric Amyloid-β and Reverses Cognitive Deficits in Alzheimer Transgenic Mice
por: Lee, Sang-Hyun, et al.
Publicado: (2014)

The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
por: Brothers, Holly M., et al.
Publicado: (2018)

Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology
por: Cai, Wenwen, et al.
Publicado: (2022)

Fast Purification of Recombinant Monomeric Amyloid-β from E. coli and Amyloid-β-mCherry Aggregates from Mammalian Cells
por: Stephens, Amberley D., et al.
Publicado: (2020)

Structural Analysis of Monomeric RNA-Dependent Polymerases: Evolutionary and Therapeutic Implications
por: Jácome, Rodrigo, et al.
Publicado: (2015)

Amyloid β and Alzheimer’s Disease: Molecular Updates from Physiology to Pathology
por: Giuffrida, Maria Laura
Publicado: (2023)

Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease
por: Xiang, Yang, et al.
Publicado: (2015)

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
por: Pan, Xiao-dong, et al.
Publicado: (2011)

Blood–brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
por: Rofo, Fadi, et al.
Publicado: (2022)

Interactions between Amyloid-β and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer's Disease
por: Chuang, Jia-Ying, et al.
Publicado: (2012)

In vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ protein
por: McIntee, Farron L., et al.
Publicado: (2016)

Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
por: Kim, Dong Eun, et al.
Publicado: (2020)

Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease
por: Dawkins, Edgar, et al.
Publicado: (2014)

Bicine promotes rapid formation of β-sheet-rich amyloid-β fibrils
por: Kim, Hye Yun, et al.
Publicado: (2020)

Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer’s disease
por: Park, Sohui, et al.
Publicado: (2021)

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019)

Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
por: Doens, Deborah, et al.
Publicado: (2014)

Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer’s Disease
por: Mocanu, Cosmin Stefan, et al.
Publicado: (2020)

Acyl peptide hydrolase degrades monomeric and oligomeric amyloid-beta peptide
por: Yamin, Rina, et al.
Publicado: (2009)

Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide
por: Molina-Fernández, Rubén, et al.
Publicado: (2022)

Formation of the 42-mer Amyloid β Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer's Disease
por: Murakami, Kazuma, et al.
Publicado: (2011)

Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer’s disease
por: Kim, Min-Seok, et al.
Publicado: (2023)

Solvent exposure of Tyr10 as a probe of structural differences between monomeric and aggregated forms of the amyloid-β peptide
por: Aran Terol, Pablo, et al.
Publicado: (2015)

Neuroanatomical spread of amyloid β and tau in Alzheimer’s disease: implications for primary prevention
por: Insel, Philip S, et al.
Publicado: (2020)

Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering
por: Zhang-Haagen, Bo, et al.
Publicado: (2016)

Emergence of Alternative Structures in Amyloid Beta 1-42 Monomeric Landscape by N-terminal Hexapeptide Amyloid Inhibitors
por: Chakraborty, Srirupa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hasgbrevj4b5slr0clvh444ti1